CN105232814A - Traditional Chinese medicine composition for treating intracranial hematoma and eliminating operation sequelae - Google Patents
Traditional Chinese medicine composition for treating intracranial hematoma and eliminating operation sequelae Download PDFInfo
- Publication number
- CN105232814A CN105232814A CN201510690190.9A CN201510690190A CN105232814A CN 105232814 A CN105232814 A CN 105232814A CN 201510690190 A CN201510690190 A CN 201510690190A CN 105232814 A CN105232814 A CN 105232814A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- medicine composition
- parts
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating intracranial hematoma and eliminating operation sequelae. In traditional Chinese medicine, language disfluency or stiff tongue aphasia is caused by blood stasis blocked in the acupuncture point Lianquan; mouth paralysis salivation is caused by blood stasis blocked in channels; and hemiplegia is caused by channel impassability and blood stagnation due to blood stasis flowing in the channels. The traditional Chinese medicine composition is prepared from traditional Chinese medicine including zephyranthes candida, cornu procaprae gutturosae, clinopodium megalanthum, phyllodium pulchellum roots, common fordia roots or leaves, euonymus alatus, barleria lupulina, common exbucklandia stems and indigofera mengtzeana craib. The traditional Chinese medicine composition is decocted into a decoction by water. Through clinical experiments, the total effective rate reaches 90.0 percent; the curative effect is obviously superior to a control group; and the traditional Chinese medicine composition is worthy of being popularized and applied.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of Chinese medicine composition for the treatment of evacuation of intracranial hematoma sequela.
Background technology
Hypertensive cerebral hemorrhage is commonly encountered diseases and the frequently-occurring disease of middle-aged and elderly people, the maximum harm of hypertensive cerebral hemorrhage is " occupation time process " that the intracerebral hematoma that formed of cerebral hemorrhage and peripheral tissue edema thereof produce, early stage Minimally Invasive Surgery, hematoma is removed as far as possible before cerebral edema is formed, alleviate the cerebral edema after cerebral hemorrhage, can prevent cerebral hernia from occurring, reduce mortality rate.Therefore, but after clinical up intracranial hematoma microscopic wound dissection, though be equipped with positive doctor trained in Western medicine medical treatment, the disability rate of patient is still higher, may with cerebral hemorrhage after around hematoma, adjacent regions is even far apart region and occurs that cerebral blood flow declines widely, causes lasting ischemic lesions relevant, have morbidity hurried, recover slowly, disability rate high, patient, once morbidity, often leaves over more sequela, brings greater impact to family and society.In order to reduce its sequela further, applicant, in clinical practice for many years, adopts treatment by Chinese herbs evacuation of intracranial hematoma sequela, achieves good curative effect.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of evacuation of intracranial hematoma sequela.Motherland's medical science is thought, the fluent or stiff tongue aphasia of language is because congestion " hinders in Lianquan ", and the askew sialorrhea of mouth is that congestion " hinders in meridians ", and hemiplegia is that congestion " flees meridians ", causes " channel tunnel is obstructed ", " blood vessels stagnate ".Therefore, suitable suppressing the hyperactive liver to relieve the wind syndrome is controlled to intracranial hematoma postoperative patient, strengthening vital QI to eliminate pathogenic factors, removing blood stasis, dredge the meridian passage.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine composition of this treatment evacuation of intracranial hematoma sequela is made up of the Chinese medicine of following weight portion: Herba Zephyranthis Candidae 9-12 part, Cornu procaprae gutturosae 3-9 part, Herba Clinopodii megalanthi 15-25 part, Radix phyllodii pulchelli 15-30 part, Radix Fordiae Cauliflorae 25-35 part, Ramulus Euonymi 5-9 part, Herba Barleriae prioniitis 8-14 part, Caulis Exbucklandiae Populneae 3-6 part, Indigofera mentzeana Craib 6-10 part.
Preferably, Herba Zephyranthis Candidae 10 parts, Cornu procaprae gutturosae 6 parts, Herba Clinopodii megalanthi 20 parts, Radix phyllodii pulchelli 22 parts, Radix Fordiae Cauliflorae 30 parts, Ramulus Euonymi 7 parts, Herba Barleriae prioniitis 11 parts, Caulis Exbucklandiae Populneae 4 parts, Indigofera mentzeana Craib 8 parts.
Preparation method: above Chinese medicine is made decoction by traditional preparation methods.
Fang Zhong: Herba Zephyranthis Candidae suppressing the hyperactive liver to relieve the wind syndrome; Cornu procaprae gutturosae suppressing the hyperactive liver to relieve the wind syndrome, heat-clearing and toxic substances removing; Herba Clinopodii megalanthi suppressing liver-wind, nourish blood, regulating menstruation, to nourish heart; The promoting the circulation of blood of Radix phyllodii pulchelli removing blood stasis with potent drugs, dehumidifying detumescence; Radix Fordiae Cauliflorae dissipating blood stasis, allay excitement, reducing swelling and alleviating pain; Ramulus Euonymi eliminating stasis to stop pain; Herba Barleriae prioniitis dredge the meridian passage, clearing away heat-damp and promoting diuresis; Caulis Exbucklandiae Populneae soothing the channels and quicking the network vessels, promoting blood circulation and stopping pain; Indigofera mentzeana Craib relaxing muscles and tendons and activating QI and blood in the collateral, analgesia, antiinflammatory.
Clinical data
1, case selected by physical data all carrys out self-institute 2009 ~ 2011 years inpatient 80 examples, is divided into treatment group and matched group at random.Wherein treatment group 40 example, man 25 example, female 15 example, age 40-81 year, wherein traumatic intracranial hematoma postoperative 16 example, hypertensive cerebral hemorrhage postoperative 24 example.Matched group 40 example, man 17 example, female 23 example, 45 ~ 80 years old age, wherein postoperative 19 examples of traumatic intracranial hematoma, postoperative 21 examples of hypertensive cerebral hemorrhage.The aspects such as two groups of sexes, age, the course of disease, sequela compare there was no significant difference (P > 0.05).
2, Therapeutic Method treatment group takes Chinese medicine composition of the present invention, namely Herba Zephyranthis Candidae 10g, Cornu procaprae gutturosae 6g, Herba Clinopodii megalanthi 20g, Radix phyllodii pulchelli 22g, Radix Fordiae Cauliflorae 30g, Ramulus Euonymi 7g, Herba Barleriae prioniitis 11g, Caulis Exbucklandiae Populneae 4g, Indigofera mentzeana Craib 8g is taken, be decocted in water for oral dose, one day 1 dose, point sooner or later clothes.Matched group adopts acupuncture, massage, and does the active of paralysed limb or passive exercise.All treat 3-9 for two groups and carry out Comparison of therapeutic after individual month.
3, in the criterion of therapeutical effect guideline of clinical investigations of apoplexy " new Chinese medicine treatment " developed and published for 1993 according to Ministry of Public Health about apoplexy curative effect determinate standard, efficacy assessment standard treats front full marks 28 points, starting point is divided and is the highlyest no more than 18 points, its efficacy evaluation adopts nimodipine method: [before (treat front integration one and treat rear integration)/treatment integration] × 100%, is expressed as a percentage.1. be almost recovered: >=85%.2. effective: >=50%.3. effective: >=20%.4. invalid: < 20%.
4, therapeutic outcome: after treatment group and treatment of control group, comparitive study is in table 1
Table 1 treatment group and matched group curative effect comparison result
P value < 0.05
Detailed description of the invention
Embodiment one: take Herba Zephyranthis Candidae 10g, Cornu procaprae gutturosae 6g, Herba Clinopodii megalanthi 20g, Radix phyllodii pulchelli 22g, Radix Fordiae Cauliflorae 30g, Ramulus Euonymi 7g, Herba Barleriae prioniitis 11g, Caulis Exbucklandiae Populneae 4g, Indigofera mentzeana Craib 8g, above Chinese medicine is traditionally made decoction.
Embodiment two: take Herba Zephyranthis Candidae 9g, Cornu procaprae gutturosae 9g, Herba Clinopodii megalanthi 25g, Radix phyllodii pulchelli 30g, Radix Fordiae Cauliflorae 35g, Ramulus Euonymi 9g, Herba Barleriae prioniitis 14g, Caulis Exbucklandiae Populneae 3g, Indigofera mentzeana Craib 10g, above Chinese medicine is traditionally made decoction.
Embodiment three: take Herba Zephyranthis Candidae 12g, Cornu procaprae gutturosae 3g, Herba Clinopodii megalanthi 15g, Radix phyllodii pulchelli 15g, Radix Fordiae Cauliflorae 25g, Ramulus Euonymi 5g, Herba Barleriae prioniitis 8g, Caulis Exbucklandiae Populneae 6g, Indigofera mentzeana Craib 6g, above Chinese medicine is traditionally made decoction.
Claims (2)
1. treat a Chinese medicine composition for evacuation of intracranial hematoma sequela, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Zephyranthis Candidae 9-12 part, Cornu procaprae gutturosae 3-9 part, Herba Clinopodii megalanthi 15-25 part, Radix phyllodii pulchelli 15-30 part, Radix Fordiae Cauliflorae 25-35 part, Ramulus Euonymi 5-9 part, Herba Barleriae prioniitis 8-14 part, Caulis Exbucklandiae Populneae 3-6 part, Indigofera mentzeana Craib 6-10 part.
2. a kind of Chinese medicine composition for the treatment of evacuation of intracranial hematoma sequela as claimed in claim 1, is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Zephyranthis Candidae 10 parts, Cornu procaprae gutturosae 6 parts, Herba Clinopodii megalanthi 20 parts, Radix phyllodii pulchelli 22 parts, Radix Fordiae Cauliflorae 30 parts, Ramulus Euonymi 7 parts, Herba Barleriae prioniitis 11 parts, Caulis Exbucklandiae Populneae 4 parts, Indigofera mentzeana Craib 8 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510690190.9A CN105232814A (en) | 2015-10-13 | 2015-10-13 | Traditional Chinese medicine composition for treating intracranial hematoma and eliminating operation sequelae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510690190.9A CN105232814A (en) | 2015-10-13 | 2015-10-13 | Traditional Chinese medicine composition for treating intracranial hematoma and eliminating operation sequelae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105232814A true CN105232814A (en) | 2016-01-13 |
Family
ID=55030808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510690190.9A Pending CN105232814A (en) | 2015-10-13 | 2015-10-13 | Traditional Chinese medicine composition for treating intracranial hematoma and eliminating operation sequelae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105232814A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105902813A (en) * | 2016-05-07 | 2016-08-31 | 李建忠 | Traditional Chinese medicine composition for treating craniocerebral trauma disorders |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104056080A (en) * | 2014-07-07 | 2014-09-24 | 张秀和 | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae |
-
2015
- 2015-10-13 CN CN201510690190.9A patent/CN105232814A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104056080A (en) * | 2014-07-07 | 2014-09-24 | 张秀和 | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae |
Non-Patent Citations (1)
| Title |
|---|
| 张福会主编: "《周志杰临床经验实录》", 30 June 2013, 陕西科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105902813A (en) * | 2016-05-07 | 2016-08-31 | 李建忠 | Traditional Chinese medicine composition for treating craniocerebral trauma disorders |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102793883B (en) | Plaster for treating intervertebral disc protrusion and cervical spondylosis | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN103705670A (en) | Traditional Chinese medicine for dispelling wind, eliminating dampness and relieving pain and preparation method thereof | |
| CN102114217A (en) | Traditional Chinese medicine fumigant for treating tinea capitis | |
| CN105687587A (en) | Ointment for warming channels and dredging collaterals as well as alleviating pain | |
| CN101249237B (en) | Chinese medicine bone fracture plaster and method of preparing the same | |
| CN105056042A (en) | Medicinal liquor for treating traumatic injuries | |
| CN106309954A (en) | Plaster for treating osteopathy | |
| CN105232814A (en) | Traditional Chinese medicine composition for treating intracranial hematoma and eliminating operation sequelae | |
| CN106491741A (en) | Promoting blood circulation and stopping pain cataplasm is filled a prescription | |
| CN105497779A (en) | Traditional Chinese medicine patch for treating acute lumbar sprain | |
| CN104606455B (en) | A kind of medicament for the treatment of lumbar muscle strain | |
| CN104258285A (en) | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof | |
| CN103083602B (en) | Externally used pharmaceutical composition for treating lumbar disease | |
| CN107753896A (en) | A kind of saussurea involucrata Wind-dispelling ointment and preparation method thereof | |
| CN101934010B (en) | Plaster for treating rheumatic diseases | |
| CN106421255A (en) | Topical traditional Chinese composition and its application | |
| CN105106521A (en) | Analgesic for traumatic injuries | |
| CN105267827A (en) | External application traditional Chinese medicine for treating orthopedic diseases | |
| CN106177292A (en) | A kind of Chinese medicine composition treating apoplexy and preparation method thereof | |
| CN105031110A (en) | Traditional Chinese medicine plaster for treating cervical spondylosis and preparation method thereof | |
| CN1947785A (en) | Medicine for treating bone fracture | |
| CN105233158A (en) | Traditional Chinese medicinal composition for treating cervical spondylosis and preparation method of traditional Chinese medicinal composition | |
| CN104983882A (en) | Traditional Chinese medicine composition for treating obstructive sleep apnea and hypoventilation syndrome | |
| CN103263621B (en) | A kind of pharmaceutical composition for the treatment of lumbar spondylosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160113 |
|
| RJ01 | Rejection of invention patent application after publication |